1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Blood Screening Market - Global Market Research 2015-2019

Blood Screening Market - Global Market Research 2015-2019

  • October 2015
  • -
  • Infiniti Research Limited
  • -
  • 74 pages

About blood screening
Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. The major blood tests that are extensively used for diagnosing diseases include erythrocyte sedimentation rate (ESR), full blood count (FBC), electrolyte test, karyotyping, enzyme-linked immunosorbent assay (ELISA), C-reactive protein, liver function test, and blood cholesterol test. The market for blood screening has witnessed numerous technological advances such as shift toward the first-generation ELISA to highly advanced NAAT testing, since its inception.

Technavio's analysts forecast the global blood screening market to grow at a CAGR of 9.31% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the global blood screening market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of instruments, assays/consumables, and services for the technologies such as NAAT and multiplexed real-time PCR

Technavio's report, Global Blood Screening Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global blood screening market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- APAC
- Europe
- Latin America
- MEA
- North America

Key Vendors
- Abbott Diagnostics
- bioMérieux
- Grifols
- Roche Diagnostics

Other prominent vendors
- Alere
- BD
- Beckman Coulter
- Bio-Rad Laboratories
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech
- Enzo Biochem
- Fujirebio/Innogenetics
- Hologic
- Immunetics
- Lab21
- Meridian Bioscience
- OraSure
- Ortho Clinical Diagnostics
- Qiagen
- SeraCare
- Siemens Healthcare Diagnostics
- Thermo Fisher Scientific
- Trinity Biotech

Market driver
- Increase in number of blood donations
- For a full, detailed list, view our report

Market challenge
- Limitation of closed system
- For a full, detailed list, view our report

Market trend
- Adoption of NAAT
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Blood Screening Market - Global Market Research 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by technology
NAAT
Multiplexed real-time PCR
PART 07: Market segmentation by product
Assays and consumables
Instruments
Services
PART 08: Geographical segmentation
Blood screening systems market in Americas
Blood screening systems market in EMEA
Blood screening systems market in APAC
PART 09: Market drivers
Increase in blood donations
Awareness of blood safety
Advances in personalized medicine
PART 10: Impact of drivers
PART 11: Market challenges
Limitation of closed systems
Regulatory issues
Lack of skilled technicians
Complexity and low detection capability
PART 12: Impact of drivers and challenges
PART 13: Market trends
Implementation of NAAT
Initiatives in rare disease research
Strategic alliances
Advances in IT
PART 14: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 15: Key vendor analysis
Abbott Diagnostics
bioMerieux
Grifols
Roche Diagnostics
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global blood screening systems market segmentation
Exhibit 03: Global blood screening systems market 2014-2019 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global blood screening systems market segmentation by technology
Exhibit 06: Global NAAT systems market segmentation by adoption 2014
Exhibit 07: Grifols: Global NAAT systems market share 2014
Exhibit 08: Grifols: NAAT systems market share in US 2014
Exhibit 09: Grifols: NAAT systems market share in APAC 2014
Exhibit 10: Roche Diagnostics and Grifols: Global NAAT systems market share 2014
Exhibit 11: Percentage share of products used for blood screening 2014
Exhibit 12: Comparison of NAAT systems for simultaneous detection of HIV, HCV (RNA), and HBV (DNA)
Exhibit 13: Global NAAT systems market 2014-2019 ($ billions)
Exhibit 14: Global multiplexed real-time PCR systems market 2014-2019 ($ billions)
Exhibit 15: Global blood screening systems market segmentation by technology 2014
Exhibit 16: Global blood screening systems market segmentation by technology 2019
Exhibit 17: Global blood screening systems market segmentation by technology 2014-2019
Exhibit 18: Global blood screening systems market segmentation by product
Exhibit 19: Global blood screening systems market segmentation by product 2014
Exhibit 20: Global blood screening systems market segmentation by geography 2014
Exhibit 21: Global blood screening systems market segmentation by geography 2019
Exhibit 22: Global blood screening systems market segmentation by geography 2014-2019
Exhibit 23: List of blood donation organizations in Americas
Exhibit 24: Blood screening systems market in Americas 2014-2019 ($ billions)
Exhibit 25: List of blood donation organizations in Europe
Exhibit 26: Number of healthcare facilities in Europe with NAAT systems
Exhibit 27: Application of NAAT systems in Europe
Exhibit 28: Blood screening systems market in EMEA 2014-2019 ($ billions)
Exhibit 29: List of blood donation organizations in APAC
Exhibit 30: Blood screening systems market in APAC 2014-2019 ($ billions)
Exhibit 31: Impact of drivers
Exhibit 32: Impact of drivers and challenges
Exhibit 33: NAATs for blood screening
Exhibit 34: Difference between NAAT and ELISA
Exhibit 35: Global blood screening systems market: Ranking of companies 2014
Exhibit 36: Grifols: Key takeaways
Exhibit 37: Roche Diagnostics: Key takeaways
Exhibit 38: Abbott Diagnostics: Key takeaways
Exhibit 39: bioMerieux: Key takeaways
Exhibit 40: Abbott Diagnostics: Key business offerings
Exhibit 41: bioMerieux: Clinical applications
Exhibit 42: Grifols: Business segmentation by revenue 2014
Exhibit 43: Grifols: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 44: Grifols: Geographical segmentation by revenue 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Blood Screening Market by Technology, ELISA,, Rapid Test, NGS, Western Blotting), Product & End User - Global Forecasts to 2021

Blood Screening Market by Technology, ELISA,, Rapid Test, NGS, Western Blotting), Product & End User - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%. The global blood screening market is categorized based on technology, product ...

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...

Blood Collection, Processing, Management Devices & Consumables Global Market - Forecast To 2023

Blood Collection, Processing, Management Devices & Consumables Global Market - Forecast To 2023

  • $ 4950
  • Industry report
  • January 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

Blood collection, processing, management devices & consumables are class of medical devices used for collecting the whole blood from the donor, segregating the collected blood into blood components like ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.